Numico Research Develops a Baby Milk for Mothers who Cannot Breastfeed
Numico Research has developed a proprietary prebiotic mixture of oligosaccharides that delivers the key benefits of breast milk for the development of the infant immune system.
14/08/06 A clinical trial with this formula, performed by Prof.dr. G. Moro of the renowned Macedonia Melloni Maternity Hospital in Milan, concludes that infants receiving Numico's proprietary prebiotic infant formula show 60 percent less eczema compared with a classical HA-formula. Eczema is the most common infant allergy.
More than 20 percent of all children are affected by allergies and the incidence has been steadily increasing over the past decades. Among infants with eczema, 75 percent will develop hay fever and half of these children will go on to develop asthma in later life. Based on the composition of breast milk, Numico Research has developed a proprietary prebiotic mixture of oligosaccharides that delivers the key benefits of breast milk for the development of the infant immune system. This specific prebiotic mixture is patent- protected.
The results of the study by Prof.dr. G. Moro have been published in the online version of the renowned British medical journal, Archives of Disease in Childhood (Arch Dis Child. Published Online First: 27 July 2006 doi: 10.1136/adc.2006.098251).
